Findings based on large study of patients with type 2 diabetes

This week we have a couple of features that could have been for my wife. The first is a feature that shows the value of e-bikes and fitness, and the second is an item from our PharmD candidate Kennen Munoz Munoz on the addition of an SGLT-2 Inhibitor to insulin …

Adding an SGLT2 inhibitor to insulin therapy for patients with type 2 diabetes who'd required large doses of insulin helped them reduce their insulin dose.

New study finds late onset diabetes early sign of pancreatic cancer; African Americans with type 2 diabetes mellitus (T2DM) at a higher risk of developing pancreatic cancer relative to other ethnic groups.

It is time to wake up and smell the coffee (roses) -- Study finds; by providing free A1c tests at all check-ups we could find most of those with prediabetes.

Diet control and insulin-treated gestational diabetes lead to neonatal hypoglycemia.

Medication reconciliation reduces emergency room visits in patients with diabetes.

Diabetes linked to risk for Parkinson's disease: people with type 2 diabetes may have an increased risk of having a diagnosis of Parkinson's later in life, according to a large study. In addition, the risk may be higher for younger people and those with complications from the disease.

How comfortable are you with prescribing a SGLT-2 inhibitor? Follow the link to see how you and your colleagues compare.

A 72-year-old patient arrives in your office complaining of shakiness and sweating before he went to bed the previous night. He doesn’t recall checking his blood glucose level at the time, however he felt better after a glass of milk and a few graham crackers. His current medications are metformin, pioglitazone, and glyburide. Which one of the following medications is the most likely cause of his symptoms?

A. Metformin
B. Pioglitazone
C. Glyburide